Home/Filings/4/0001437749-23-024417
4//SEC Filing

Ostronic Francis Patrick 4

Accession 0001437749-23-024417

CIK 0000922247other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 4:07 PM ET

Size

4.8 KB

Accession

0001437749-23-024417

Insider Transaction Report

Form 4
Period: 2023-08-18
Transactions
  • Award

    Common Stock

    2023-08-18+10,111259,182 total
Footnotes (1)
  • [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the second quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.36 per share of common stock on August 18, 2023.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001570620

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:07 PM ET
Size
4.8 KB